Other Cancer Types
Additional itraconazole oncology evidence across Hedgehog-driven, angiogenesis-driven, and resistant tumour settings
Itraconazole's mechanism profile gives it relevance beyond the headline prostate, NSCLC, basal cell, ovarian, breast, and pancreatic pages.
Additional areas of interest
other Hedgehog-driven tumours
angiogenesis-heavy cancers
resistant cancers where multidrug-resistance reversal matters
Practical interpretation
This page is a holding space for future expansion as more cancer-specific itraconazole notes are added.
References
Repurposed itraconazole for use in the treatment of malignancies as a promising therapeutic strategy
https://www.sciencedirect.com/science/article/abs/pii/S1043661821003328
Repurposing itraconazole as an anticancer agent
https://pmc.ncbi.nlm.nih.gov/articles/PMC5536437/
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.